Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$2.6B |
| 2 |
Abbott
ABT
|
+$1.29B |
| 3 |
Home Depot
HD
|
+$1.03B |
| 4 |
Devon Energy
DVN
|
+$888M |
| 5 |
PepsiCo
PEP
|
+$880M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$1.6B |
| 2 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$1.5B |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$1.34B |
| 4 |
Texas Instruments
TXN
|
+$1.32B |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$789M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Financials | 10.61% |
| 3 | Healthcare | 10.33% |
| 4 | Miscellaneous | 9.93% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Strategic Education
STRA
$1.81B
| $26M | ﹤0.01% |
339,542
-14,363
| -4% | -$1.14M |
|
1677
Calix
CALX
$2.17B
| $26M | ﹤0.01% |
696,967
+15,013
| +2% | +$630K |
|
1678
PDF Solutions
PDFS
$1.99B
| $26M | ﹤0.01% |
367,090
+58,916
| +19% | +$2.92M |
|
1679
Teladoc Health
TDOC
$1.11B
| $26M | ﹤0.01% |
3,063,252
+25,278
| +0.8% | +$168K |
|
|
KEEL
1680
Keel Infrastructure Corp
KEEL
$2.29B
| $26M | ﹤0.01% |
+4,523,803
| New | +$19.4M |
|
1681
Centuri Holdings
CTRI
$2.04B
| $25.9M | ﹤0.01% |
855,123
+80,973
| +10% | +$2.61M |
|
1682
MillerKnoll
MLKN
$1.49B
| $25.9M | ﹤0.01% |
1,263,574
-282,234
| -18% | -$4.52M |
|
1683
Banc of California
BANC
$2.92B
| $25.8M | ﹤0.01% |
1,262,648
-1,623
| -0.1% | -$30.9K |
|
1684
Rogers Communications
RCI
$19.7B
| $25.8M | ﹤0.01% |
792,637
+63,209
| +9% | +$2.28M |
|
|
DEA
1685
Easterly Government Properties
DEA
$1.13B
| $25.7M | ﹤0.01% |
1,030,664
+20,748
| +2% | +$487K |
|
1686
Hamilton Lane
HLNE
$4.29B
| $25.6M | ﹤0.01% |
325,095
+4,495
| +1% | +$400K |
|
1687
Yelp
YELP
$1.11B
| $25.6M | ﹤0.01% |
1,042,902
-43,968
| -4% | -$1.1M |
|
1688
G-III Apparel Group
GIII
$1.16B
| $25.5M | ﹤0.01% |
756,238
-120,742
| -14% | -$3.81M |
|
1689
Pegasystems
PEGA
$5.76B
| $25.4M | ﹤0.01% |
848,744
-23,960
| -3% | -$857K |
|
1690
Agilysys
AGYS
$2.99B
| $25.4M | ﹤0.01% |
242,929
+6,028
| +3% | +$467K |
|
1691
Ultragenyx Pharmaceutical
RARE
$1.41B
| $25.4M | ﹤0.01% |
760,039
+201,553
| +36% | +$5.01M |
|
1692
BancFirst
BANF
$3.72B
| $25.4M | ﹤0.01% |
228,190
+23,793
| +12% | +$2.67M |
|
|
SVC
1693
Service Properties Trust
SVC
$921M
| $25.3M | ﹤0.01% |
2,993,539
+1,426,589
| +91% | +$11.2M |
|
1694
ImmunityBio
IBRX
$8.54B
| $25.3M | ﹤0.01% |
2,888,607
+410,666
| +17% | +$3.11M |
|
1695
Adaptive Biotechnologies
ADPT
$3.9B
| $25.3M | ﹤0.01% |
1,178,552
+32,870
| +3% | +$504K |
|
1696
Edgewise Therapeutics
EWTX
$4.71B
| $25.2M | ﹤0.01% |
620,532
+24,222
| +4% | +$835K |
|
1697
Levi Strauss
LEVI
$7.83B
| $25.2M | ﹤0.01% |
1,015,041
-52,276
| -5% | -$1.18M |
|
1698
Integra LifeSciences
IART
$1.26B
| $25.2M | ﹤0.01% |
1,401,476
-210,669
| -13% | -$2.95M |
|
1699
Independent Bank Corp
IBCP
$816M
| $25.2M | ﹤0.01% |
697,724
+74,697
| +12% | +$2.56M |
|
1700
Shift4
FOUR
$3.25B
| $25.1M | ﹤0.01% |
515,500
-22,435
| -4% | -$970K |
|
Similar funds
Charles Schwab's Q2 2026 Portfolio in Review
As of Q2 2026, Charles Schwab held 3,591 positions worth $751B, up 15% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab's Q2 2026 filing shows 136 new, 2,145 increased, 1,132 reduced and 153 closed positions. Its largest new stake was Honeywell Aerospace: 2,031,187 shares worth $449M. The largest sale was Qualcomm, an estimated $1.6B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2026 buy was Honeywell Aerospace: 2,031,187 shares worth $449M.
- Charles Schwab added most to Schwab US Large-Cap Growth ETF in Q2 2026, an estimated $2.6B increase.
- Charles Schwab's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $1.6B.
- Charles Schwab fully exited Coterra Energy in Q2 2026, selling an estimated $789M.
- Charles Schwab's ten largest holdings make up 22% of its $751B portfolio in Q2 2026.
- Charles Schwab opened 136 new positions and closed 153 in Q2 2026.
- Charles Schwab's portfolio value rose 15% quarter-over-quarter to $751B.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.